Jesús Domínguez-RojasPablo Vásquez‐HoyosRodrigo Pérez-MoralesAna María Monsalve-QuinteroLupe Mora-RoblesAlejandro DíazSilvio TorresÁngel Castro-DajerLizeth Yuliana Cabanillas-BurgosVladimir Aguilera-Avendaño2026-03-222026-03-22202210.3389/fped.2022.885633https://doi.org/10.3389/fped.2022.885633https://andeanlibrary.org/handle/123456789/47705Citaciones: 14Our study shows that pediatric patients with new onset diagnosis of cancer and patients with relapse have higher odds of all-cause mortality in the setting of COVID-19. This information would help develop an early identification of patients with cancer and COVID-19 with higher risk of mortality.enMedicineCancerProspective cohort studyPediatric cancerPediatricsMortality ratePopulationCohortInternal medicineAssociation of Cancer Diagnosis and Therapeutic Stage With Mortality in Pediatric Patients With COVID-19, Prospective Multicenter Cohort Study From Latin Americaarticle